Summary (tl;dr)

Multiple eye drop products from various brands have been recalled recently by the U.S. Food and Drug Administration (FDA) due to concerns about sterility and potential contamination, prompting consumers to check their medicine cabinets.

Essential Background

Over the past few years, there have been several recalls of eye drops due to safety concerns, including reports of infections, partial vision loss, and blindness. A notable instance in 2023 involved artificial tears linked to an outbreak of drug-resistant bacteria, Pseudomonas aeruginosa, resulting in infections, vision loss, and four deaths. These past events underscore the critical importance of sterility in ophthalmic products, as they bypass some of the body's natural defenses and pose a heightened risk of harm if contaminated.

The Full Story

"Eye drops recalled" is trending due to a series of recent nationwide recalls of various over-the-counter eye drop and ophthalmic ointment products, primarily stemming from a "lack of assurance of sterility" during manufacturing. Most recently, in October 2026, nearly 750,000 units across nine different brand names, including Walgreens, AvKare, and Reliable-1 Laboratories, were subject to a Class II recall initiated by Illinois-based Sterling Pharmaceutical Services LLC. This was officially classified as a Class II health risk by the FDA on September 21, 2026.

In August 2026, Prestige Consumer Healthcare voluntarily recalled approximately 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief eye drops nationwide, also due to sterility concerns. Earlier in 2026, over 3 million bottles of various eye drops were recalled, again due to a lack of sterility assurance. Additionally, Lupin Pharmaceuticals Inc. initiated a voluntary recall of 2.5 million bottles of prescription eye drops due to the potential presence of a "foreign substance". These ongoing recalls highlight a recurring issue within the eye care product industry regarding manufacturing standards and product safety.

Why It Matters

These recalls are significant because non-sterile eye products can lead to serious health consequences, including eye infections, vision loss, and in severe cases, blindness or even death. Ophthalmic products are particularly sensitive as they directly interact with eye tissue, bypassing the body's natural defenses. Consumers are urged to check their eye drop products against the recall lists provided by the FDA and discard any affected items immediately to prevent potential harm. The widespread nature of these recalls, affecting major retailers and multiple brands, indicates a systemic concern regarding the manufacturing processes for these commonly used over-the-counter and prescription products.

Geographic Location

• Dupo, St. Clair County, Illinois, United States (manufacturing location of recalled eye drops by Sterling Pharmaceutical Services)
• Tarrytown, Westchester County, New York, United States (headquarters of Prestige Consumer Healthcare, which initiated Clear Eyes recall)
• Mumbai, Maharashtra, India (manufacturing location of some previously recalled eye drops by Kilitch Healthcare India Limited)
• Virtual/Online (nationwide distribution and sale of recalled products through major retailers like Walgreens, CVS, Target, Walmart, Kroger, Rite Aid, Dollar General, and Family Dollar)